{
    "Trade/Device Name(s)": [
        "Coag-Sense Prothrombin Time (PT) / INR Monitoring System for Patient Self-Testing"
    ],
    "Submitter Information": "CoaguSense, Inc.",
    "510(k) Number": "K212779",
    "Predicate Device Reference 510(k) Number(s)": [
        "K183255"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GJS"
    ],
    "Summary Letter Date": "September 20, 2022",
    "Summary Letter Received Date": "September 01, 2021",
    "Submission Date": "September 01, 2021",
    "Regulation Number(s)": [
        "21 CFR 864.7750"
    ],
    "Regulation Name(s)": [
        "Prothrombin Time Test"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Prothrombin Time (PT)",
        "International Normalized Ratio (INR)"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Coag-Sense Prothrombin Time (PT) / INR Monitoring System meter"
    ],
    "Method(s)/Technology(ies)": [
        "Micromechanical end point detection",
        "Clot detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "System",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for Coag-Sense Prothrombin Time (PT) / INR Monitoring System for Patient Self-Testing, a handheld device for quantitative PT/INR measurement from fingerstick whole blood",
    "Indications for Use Summary": "Provides quantitative PT results in INR units from fresh capillary whole blood for patient self-testing to monitor anticoagulation therapy on physician's order; not for screening and intended for single person use",
    "fda_folder": "Hematology"
}